Mosso Lorena M, Carvajal Cristian A, Maiz Alberto, Ortiz Eugenia H, Castillo Carmen R, Artigas Rocío A, Fardella Carlos E
Department of Nutrition and Diabetes, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
J Hypertens. 2007 Oct;25(10):2125-30. doi: 10.1097/HJH.0b013e3282861fa4.
Primary aldosteronism (PA) is the most common secondary cause of hypertension and recently has been implicated as a cause of impaired glucose tolerance. We investigated the glucose insulin sensitivity and insulin secretion in patients with idiopathic primary aldosteronism.
Thirty PA patients and 60 essential hypertensive (EH) patients as controls were included, matched (1: 2) by their body mass index (BMI) (29.9 +/- 4.3 versus 29.8 +/- 5.8 m/kg), age (53.7 +/- 9.4 versus 59.9 +/- 8.6 years old) and gender (male/female: 8/22 versus 17/43). In all patients, we measured insulin, total cholesterol, triglycerides, C-peptide and fasting glucose levels. Homeostasis model assessment for insulin resistance (HOMA-IR) and HOMA of pancreatic beta-cell function (HOMA-betaF) indexes were calculated. We also evaluated the response to spironolactone in 19 PA patients.
PA patients had higher levels of glucose (5.2 +/- 0.7 versus 4.9 +/- 0.7 mmol/l; P = 0.017). Insulin levels (10.7 +/- 6.5 versus 11.5 +/- 5.8 uUI/ml, P = 0.525) and HOMA-IR (2.51 +/- 1.59 versus 2.45 +/- 1.29 uUI/ml x mmol/l, P = 0.854) were similar in both groups. HOMA-betaF index (138.9 +/- 89.8 versus 179.8 +/- 100.2%, P = 0.049) and C-peptide (0.83 +/- 0.63 versus 1.56 +/- 0.84 ng/dl, P = 0.0001) were lower in PA patients. Potassium was normal in both groups. Negative correlations between serum aldosterone/plasma renin activity (SA/PRA) ratio and HOMA-betaF, and between C-peptide and SA levels were found in all patients. After the spironolactone treatment, we found an increase of C-peptide and insulin levels without changes in HOMA-IR or HOMA-betaF.
Our results showed differences in glucose metabolism between PA patients and those with hypertension suggesting that these findings could probably be determined by a lower beta-cell function influenced by aldosterone. These findings highlight the importance of aldosterone in glucose metabolism.
原发性醛固酮增多症(PA)是高血压最常见的继发性病因,最近被认为是糖耐量受损的一个原因。我们研究了特发性原发性醛固酮增多症患者的葡萄糖胰岛素敏感性和胰岛素分泌情况。
纳入30例PA患者和60例原发性高血压(EH)患者作为对照,根据体重指数(BMI)(29.9±4.3与29.8±5.8m/kg)、年龄(53.7±9.4与59.9±8.6岁)和性别(男/女:8/22与17/43)进行匹配(1:2)。对所有患者,我们测量了胰岛素、总胆固醇、甘油三酯、C肽和空腹血糖水平。计算胰岛素抵抗的稳态模型评估(HOMA-IR)和胰腺β细胞功能的HOMA(HOMA-βF)指数。我们还评估了19例PA患者对螺内酯的反应。
PA患者的血糖水平较高(5.2±0.7与4.9±0.7mmol/l;P=0.017)。两组的胰岛素水平(10.7±6.5与11.5±5.8uUI/ml,P=0.525)和HOMA-IR(2.51±1.59与2.45±1.29uUI/ml×mmol/l,P=0.854)相似。PA患者的HOMA-βF指数(138.9±89.8与179.8±100.2%,P=0.049)和C肽(0.83±0.63与1.56±0.84ng/dl,P=0.0001)较低。两组的血钾均正常。在所有患者中发现血清醛固酮/血浆肾素活性(SA/PRA)比值与HOMA-βF之间以及C肽与SA水平之间呈负相关。螺内酯治疗后,我们发现C肽和胰岛素水平升高,而HOMA-IR或HOMA-βF无变化。
我们的结果显示PA患者与高血压患者在糖代谢方面存在差异,提示这些发现可能是由醛固酮影响的较低β细胞功能所决定。这些发现突出了醛固酮在糖代谢中的重要性。